VF-210.42 is a novel plant-derived formulation designed as a peptide mimetic of bremelanotide (PT-141), a melanocortin-4 receptor agonist used to treat hypoactive sexual desire disorder (HSDD). Unlike hormonal therapies, PT-141 enhances libido via central nervous system (CNS) pathways without altering endocrine levels. VF-210.42 combines seven bioactive botanicals – Muira puama, Damiana, Maca, Horny Goat Weed (Epimedium), Catuaba, Tribulus terrestris, and Saffron – selected for their synergistic aphrodisiac properties and mechanistic overlap with melanocortin pathway effects.
